Fenchem Performs Clinical Test on Sodium Hyaluronate
Fenchem Enterprises Ltd., Nanjing, China, is currently conducting clinical tests on its sodium hyaluronate (HA) product, Hyamax, in relation to joint health. HA is a mucopolysaccharide with variable molecular weights. Through comparing the distribution and metabolizing of HA with different molecular weights in animal and human systems, Fenchem expects to determine proper consumption for consumers and reveal the appropriate molecular weight for the highest absorption and efficiency in joint health.